Long-term use of rituximab associated with lower rates of AAV relapse
1. In this randomized controlled trial involving patients with antineutrophil cytoplasmic antibody-associated vasculitis in complete remission, administration of rituximab for ...
Tag: rituximab
#VisualAbstract: Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
1. In this randomized control trial of neuromyelitis optica spectrum disorder (NMOSD) patients with aquaporin-4 antibodies (AQP4-IgG), those randomized to ...
#VisualAbstract: Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
1. Previously untreated chronic lymphocytic leukemia (CLL) patients experienced increased progression-free and overall survival when treated with ibrutinib-rituximab compared to ...
The PREVENT trial: eculizumab reduces relapse risk in patients with neuromyelitis optica and aquaporin-4 antibodies
1. In this randomized control trial of neuromyelitis optica spectrum disorder (NMOSD) patients with aquaporin-4 antibodies (AQP4-IgG), those randomized to ...
Survival increased in chronic lymphocytic leukemia patients treated with ibrutinib and rituximab
1. Previously untreated chronic lymphocytic leukemia (CLL) patients experienced increased progression-free and overall survival when treated with ibrutinib-rituximab compared to ...
In phase 3 trial, rituximab not associated with clinical improvement in patients with Myalgic encephalomyelitis/chronic fatigue syndrome
1. In this randomized controlled trial, B-lymphocyte depletion through rituximab did not significantly improve fatigue symptoms of patients with ME/CFS ...
Quick Take: Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
Tumour necrosis factor (TNF) alpha inhibitors have greatly improved disease control and quality of life in patients affected by rheumatoid ...
2 Minute Medicine Rewind January 28, 2019
Association of HLA antigen mismatch with risk of developing skin cancer after solid-organ transplant Immunosuppressive agents reduce the risk of ...
Quick Take: Association of Rituximab Treatment with Disability Progression Among Patients with Secondary Progressive Multiple Sclerosis
Secondary progressive multiple sclerosis (SPMS) is the second most common type of multiple sclerosis, a demyelinating syndrome of the central ...
2 Minute Medicine Rewind January 14, 2019
An Evaluation of the Effects of Lowering Blood Alcohol Concentration Limits for Drivers on the Rates of Road Traffic Accidents ...
